Benchmark of High Content Screening platform
With Fluofarma, choose reliability at high speed
A technological benchmark of the different High Content Screening platforms
proved that Fluofarma is the unique platform combining a large
number of cells individually analyzed with quantitative
measures of molecular events.
Benchmark of HCS platforms
Breaking news
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the journal Biochimica et Biophysica Acta - Molecular Cell Research.Read more [+]
IFSCC 2008
Fluofarma will be attending IFSCC 2008, in Barcelona, from October 6th to 9th.Read more [+]
INVITOX 2008
Fluofarma will be attending the INVITOX 2008 meeting, in Stockholm from September 25th to 28th.Read more [+]
EuroBio 2008
Fluofarma will be attending EuroBio 2008, in Paris from October 7th to 9th.Read more [+]
SMi's Cell-Based Assays 2008
Fluofarma will be attending SMi's Cell-Based Assays conference, in London from November 19th to 20th.Read more [+]
GDDI Forum 2009
Fluofarma will be attending Global Discovery & Development Innovation Forum 2009, in London, from March 2nd to 3rd.Read more [+]
FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to
compare and profile your anti-cancer drugs. Read
more [+]